Impact of exacerbations on adherence and outcomes of pulmonary rehabilitation in patients with COPD

Respirology

Volumn 22, Issue 5, 2017, Pages 942-949

  Braeken, Dionne C W ^a,b   Spruit, Martijn A ^a   Houben Wilke, Sarah ^a   Smid, Dionne E ^a   Rohde, Gernot G U ^b   Wouters, Emiel F M ^a,b   Franssen, Frits M E ^a,b  

^a CIRO   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

chronic obstructive pulmonary disease; dropout; exacerbations; pulmonary rehabilitation; response

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT COMPLIANCE; PATIENT DROPOUT; PREDICTION; PRIORITY JOURNAL; PULMONARY REHABILITATION; SIX MINUTE WALK TEST; TREATMENT OUTCOME; AGED; ANXIETY; COMPLICATION; DEPRESSION; HOSPITALIZATION; LONGITUDINAL STUDY; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGY; QUESTIONNAIRE;

AGED; ANXIETY; DEPRESSION; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HOSPITALIZATION; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 85011632775     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12987     Document Type: Article

References (36)

1. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD et al.; ATS/ERS Task Force on Pulmonary Rehabilitation. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2013; 188: e13–64.
2. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2015; 2: CD003793.
3. Garrod R, Marshall J, Barley E, Jones PW. Predictors of success and failure in pulmonary rehabilitation. Eur. Respir. J. 2006; 27: 788–94.
4. Spruit MA, Augustin IM, Vanfleteren LE, Janssen DJ, Gaffron S, Pennings HJ, Smeenk F, Pieters W, van den Bergh JJ, Michels AJ et al.; on behalf of the CIRO+ Rehabilitation Network. Differential response to pulmonary rehabilitation in COPD: multidimensional profiling. Eur. Respir. J. 2015; 46: 1625–35.
5. Keating A, Lee A, Holland AE. What prevents people with chronic obstructive pulmonary disease from attending pulmonary rehabilitation? A systematic review. Chron. Respir. Dis. 2011; 8: 89–99.
6. Fischer MJ, Scharloo M, Abbink JJ, van 't Hul AJ, van Ranst D, Rudolphus A, Weinman J, Rabe KF, Kaptein AA. Drop-out and attendance in pulmonary rehabilitation: the role of clinical and psychosocial variables. Respir. Med. 2009; 103: 1564–71.
7. Sadatsafavi M, Sin DD, Zafari Z, Criner G, Connett JE, Lazarus S, Han M, Martinez F, Albert R. The association between rate and severity of exacerbations in chronic obstructive pulmonary disease: an application of a Joint Frailty-Logistic Model. Am. J. Epidemiol. 2016; DOI: 10.1093/aje/kww085.
8. Steele BG, Belza B, Cain K, Coppersmith J, Howard J, Lakshminarayan S, Haselkorn J. The impact of chronic obstructive pulmonary disease exacerbation on pulmonary rehabilitation participation and functional outcomes. J. Cardiopulm. Rehabil. Prev. 2010; 30: 53–60.
9. Smid DE, Wilke S, Jones PW, Muris JW, Wouters EF, Franssen FM, Spruit MA. Impact of cardiovascular comorbidities on COPD Assessment Test (CAT) and its responsiveness to pulmonary rehabilitation in patients with moderate to very severe COPD: protocol of the Chance study. BMJ Open 2015; 5: e007536.
10. Smid DE, Franssen FM, Houben-Wilke S, Vanfleteren LE, Janssen DJ, Wouters EF, Spruit MA. Responsiveness and MCID estimates for CAT, CCQ, and HADS in patients with COPD undergoing pulmonary rehabilitation: a prospective analysis. J. Am. Med. Dir. Assoc. 2017; 18: 53–58.
11. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2015. [Accessed 17 Feb 2015.] Available from URL: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html.
12. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur. Respir. J. 2009; 34: 648–54.
13. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am. Rev. Respir. Dis. 1992; 145: 1321–7.
14. van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual. Life Outcomes 2003; 1: 13.
15. Marin A, Garcia-Aymerich J, Sauleda J, Belda J, Millares L, Garcia-Nunez M, Serra I, Benet M, Agusti A, Anto JM et al.; on behalf of the PAC-COPD Study Group. Effect of bronchial colonisation on airway and systemic inflammation in stable COPD. COPD 2012; 9: 121–30.
16. Soler-Cataluna JJ, Cosio B, Izquierdo JL, Lopez-Campos JL, Marin JM, Aguero R, Baloira A, Carrizo S, Esteban C, Galdiz JB et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch. Bronconeumol. 2012; 48: 331–7.
17. Bajc M, Markstad H, Jarenback L, Tufvesson E, Bjermer L, Jogi J. Grading obstructive lung disease using tomographic pulmonary scintigraphy in patients with chronic obstructive pulmonary disease (COPD) and long-term smokers. Ann. Nucl. Med. 2015; 29: 91–9.
18. Puhan MA, Frey M, Buchi S, Schunemann HJ. The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease. Health Qual. Life Outcomes 2008; 6: 46.
19. Marin A, Monso E, Garcia-Nunez M, Sauleda J, Noguera A, Pons J, Agusti A, Morera J. Variability and effects of bronchial colonisation in patients with moderate COPD. Eur. Respir. J. 2010; 35: 295–302.
20. Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, McCormack MC, Carlin BW, Sciurba FC, Pitta F et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur. Respir. J. 2014; 44: 1428–46.
21. van 't Hul A, Gosselink R, Kwakkel G. Constant-load cycle endurance performance: test-retest reliability and validity in patients with COPD. J. Cardiopulm. Rehabil. 2003; 23: 143–50.
22. Laviolette L, Bourbeau J, Bernard S, Lacasse Y, Pepin V, Breton MJ, Baltzan M, Rouleau M, Maltais F. Assessing the impact of pulmonary rehabilitation on functional status in COPD. Thorax 2008; 63: 115–21.
23. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann. Intern. Med. 1987; 106: 196–204.
24. Hayton C, Clark A, Olive S, Browne P, Galey P, Knights E, Staunton L, Jones A, Coombes E, Wilson AM. Barriers to pulmonary rehabilitation: characteristics that predict patient attendance and adherence. Respir. Med. 2013; 107: 401–7.
25. Brown AT, Hitchcock J, Schumann C, Wells JM, Dransfield MT, Bhatt SP. Determinants of successful completion of pulmonary rehabilitation in COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 2016; 11: 391–7.
26. Degens H, Gayan-Ramirez G, van Hees HW. Smoking-induced skeletal muscle dysfunction: from evidence to mechanisms. Am. J. Respir. Crit. Care Med. 2015; 191: 620–5.
27. Hill I, Williams AJ, Shaw TJ. Should smokers be allowed to attend pulmonary rehabilitation? Thorax 2008; 63: 405–413.
28. Wilkinson TM, Donaldson GC, Hurst JR, Seemungal TA, Wedzicha JA. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2004; 169: 1298–303.
29. Pavord ID, Jones PW, Burgel PR, Rabe KF. Exacerbations of COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 2016; 11: 21–30.
30. Mullerova H, Maselli DJ, Locantore N, Vestbo J, Hurst JR, Wedzicha JA, Bakke P, Agusti A, Anzueto A; ECLIPSE Investigators. Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort. Chest 2015; 147: 999–1007.
31. Troosters T, Probst VS, Crul T, Pitta F, Gayan-Ramirez G, Decramer M, Gosselink R. Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2010; 181: 1072–7.
32. Puhan M, Scharplatz M, Troosters T, Walters EH, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2009; 21: CD005305.
33. Giavedoni S, Deans A, McCaughey P, Drost E, MacNee W, Rabinovich RA. Neuromuscular electrical stimulation prevents muscle function deterioration in exacerbated COPD: a pilot study. Respir. Med. 2012; 106: 1429–34.
34. Menadue C, Piper AJ, van 't Hul AJ, Wong KK. Non-invasive ventilation during exercise training for people with chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2014; 5: CD007714.
35. Rice KL, Dewan N, Bloomfield HE, Grill J, Schult TM, Nelson DB, Kumari S, Thomas M, Geist LJ, Beaner C et al. Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial. Am. J. Respir. Crit. Care Med. 2010; 182: 890–6.
36. Williams V, Hardinge M, Ryan S, Farmer A. Patients' experience of identifying and managing exacerbations in COPD: a qualitative study. NPJ Prim. Care Respir. Med. 2014; 24: 14062.